- Investing Ideas
- Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Shanghai Allist Pharmaceuticals
Market Cap: CN¥58.9b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥130.58
7D
22.0%
1Y
41.6%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥54.4b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥57.52
7D
15.6%
1Y
58.9%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥14.9b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥42.25
7D
1.9%
1Y
18.7%